Yunpeng Pharmaceutical
Yunpeng Pharmaceutical Group is a comprehensive high-tech enterprise integrating drug research and development, production, sales and logistics. It has 200 approval numbers, 9 subsidiaries and 1 branch, with a total asset value of 1.5 billion yuan. The Group has a modern production base and a R&D pilot base with chemical drugs, traditional Chinese medicines and raw materials as the core; one of the traditional Chinese medicine extraction production lines, four R&D pilot production lines, ten oral preparation production lines, eleven chemical raw materials production lines and injection molding production lines are all Passed the new version of GMP certification. The EU workshop of raw materials and the EU workshop of oral preparations will be completed soon.
The group invested 100 million yuan in 2018 to establish Beijing Yunpeng Pengcheng Pharmaceutical Research Institute, investing 8-10% of its profits in R&D every year, and cooperated with 6 companies including the international pharmaceutical giant Fangteda Co., Ltd. It has successively won the titles of "Technology Innovation Enterprise" and "High-tech Enterprise".
The group has successively established business cooperation relations with many countries such as India, Japan, the United Kingdom, and South Korea, and its sales network is spread all over the world. At present, norfloxacin, indomethacin, and Mexillitus hydrochloride have completed registration in India. At the same time, indomethacin has completed registration in Russia, Mexico, Egypt, South Korea and other places. In Japan, mexire hydrochloride and vitamin U have also been approved by JDMF.
The group introduced management concepts and created industrial, informatized and intelligent enterprises. At the same time, it obtained environmental assessment certificates, safety assessment certificates, fire protection certificates, pollutant discharge certificates, water withdrawal certificates, etc., and its strength was improved; and it was awarded the "Shanxi Provincial Management Benchmark Enterprise" and "Enterprise Environment Supervisor pilot work qualified unit” title.
In the future, Yunpengren will continue to uphold the corporate mission of "contributing to society and delivering health to the people", and spread health and protect life with more, newer and better health products in the cause of human health!
Brand: FOSHAN PHARMA
Main Products: Tetanus Antitoxin Injection , Tetanus Antiserum , Human Hepatitis B Immunoglobulin , Oxytocin Injection , Natural essential oil , Biological Product For Human
Shaanxi YXchuang Biotechnology Co., Ltd
Brand: YXchuang
Main Products: API Powder , Pharmaceutical Intermediates , Vitamins Powder , Plant Extracts , Food Additive , Peptide Powder
Brand: NOUVASANT
Main Products: Finished Pharmaceutical Product , API & Raw materials , Antimalarial , Antibiotic & Antimicrobial , Medical Disposables , Antifungal Drugs
NANYANG CHENGPENG PHARMACEUTICAL CO.,LTD
Brand: CHENGPENG
Main Products: Veterinary APIS , Veterinary Premix APIs , Veterinary Soluble Powder , Feed Additives , Food Additives , Extracts for Animal
Brand: ERA Medicals
Main Products: Medical Instruments , Medicinal Materials , Pharmaceutical Accessories , Medical Disposables , Pharmaceutical Excipients , Medical Supplies
